特集 神経疾患治療の進歩 2018
脊髄小脳変性症の治療の進歩 2018
2019 年 36 巻 5 号 p. 580-583
詳細
2019 年 36 巻 5 号 p. 580-583
We reviewed the recent advances in therapeutics of spinocerebellar degeneration (SCD) that were published in 2018. This article introduces the outline of therapies with mesenchymal stem cells, cerebello–spinal tDCS, betamethasone, and cyclodextrin. We expect that these treatments will contribute to patients with cerebellar motor dysfunction and ataxia.
